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AbstrAct
It is well established in various experimental models that luteinizing hormone (LH) stimulated 
testosterone (T) production of Leydig cells is the key endocrine stimulus of spermatogenesis. 
The role of the other gonadotrophin, follicle-stimulating hormone (FSH), is as yet somewhat 
unclear given that several clinical conditions and experimental models, including men with 
inactivating FSH receptor (R) mutation and male Fshb and Fshr knockout mice, maintain 
fairly normal spermatogenesis and fertility. Furthermore, FSH treatment of male infertility has 
produced at best modest results. On the other hand, there are animal species (e.g. teleost fishes 
and the Djungarian hamster) where spermatogenesis is primarily FSH-dependent. The purpose 
of this article is to briefly review the gonadotrophin dependence of spermatogenesis in several 
model species and examine how it has shifted during evolution from FSH to LH dominance. 
The information may provide new insight into the role of FSH treatment of male infertility.
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InTrODucTIOn
The adult testis has two functions: the production 
of sex steroids, in particular testosterone (T), and sper-
matogenesis. Two pituitary gonadotrophic hormones, 
follicle-stimulating hormone (FSH) and luteinizing 
hormone (LH), are the pivotal endocrine regulators of 
these testicular functions. LH stimulates T production 
by Leydig cells of testicular interstitial tissue. T, on 
the one hand, is secreted into the circulation where it 
exerts its e xtragonadal sexual (potency, libido) and 
anabolic (muscle strength, bone density) actions. On 
the other hand, T has an intratesticular paracrine role 
in the maintenance of spermatogenesis, which occurs 
indirectly through stimulation of Sertoli cells present 
in the seminiferous tubules adjacent to germ cells. The 
Sertoli cells then send T-dependent paracrine stimuli 
to spermatogenic cells. Sertoli cells are also the target 
of FSH, and thus T and FSH regulate spermatogenesis 
in a similar indirect paracrine fashion.
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While it is textbook knowledge that LH-stimulated 
T production is quintessential for the maintenance of 
qualitatively and quantitatively complete spermato-
genesis, the specific role of FSH is not to date so 
clearly delineated. FSH apparently synergizes with 
T in the regulation of Sertoli cell function, but there 
are several examples from a variety of mammalian 
species showing that spermatogenesis can be initi-
ated and maintained with T alone and that sufficient, 
though quantitatively suppressed, spermatogenesis is 
possible without FSH. Moreover, considerable spe-
cies differences exist with respect to the role of FSH 
in spermatogenesis in comparison with the almost 
universal dominance of LH/T action.
The purpose of this review is to reflect on the 
role of FSH in the LH/T-dominated maintenance of 
spermatogenesis. Evidence will be presented that the 
involvement of the two gonadotrophins has taken 
different directions in the course of evolution. We 
first briefly review the hormonal regulation of sper-
matogenesis in the standard experimental models, i.e. 
the laboratory rat and mouse, and humans. Thereaf-
ter, some evolutionary milestones in this regulatory 
process, as well as notable exceptions, are described. 
This information may help us better understand the 
pathogenesis of spermatogenic failure in humans 
and offer novel strategies for the FSH treatment of 
male infertility.
rOLe OF LH anD T
Rodents
Much of the experimental work on spermatogenesis 
has been carried out in the two commonest rodent 
models, the rat and mouse. They can be discussed 
together because the role of gonadotrophins in the 
regulation of their spermatogenesis is very similar. 
Earlier studies were mainly conducted on rats, but the 
most recent research, in particular genetic manipula-
tion experiments, has been carried out on mice. Rats 
and mice have demonstrated that T is essential for 
spermatogenesis but is relatively independent of FSH. 
Rat spermatogenesis can be initiated by T treat-
ment alone in animals made gonadotrophin-deficient 
by immunization against GnRH1 or FSH2,3 or when 
treated with GnRH antagonist.3 Numerous more recent 
studies have demonstrated the same LH/T dominance 
in mouse spermatogenesis (see below).
Before puberty, T is essential for male genital 
differentiation and growth, including testicular de-
scent and Sertoli cell differentiation. The main steps 
of rodent spermatogenesis that are under T regula-
tion are meiosis and postmeiotic spermiogenesis. T 
seems to have no role in spermatogonial proliferation 
and maturation,4,5 but it supports spermatocyte and 
spermatid survival in immature rats,6 probably by 
antiapoptotic mechanisms (summarized by Ruwan-
pura et al7). Androgen receptor (AR) knockout mice 
have clearly demonstrated that spermatogenesis does 
not proceed to complete meiosis without indirect T 
action through Sertoli cells.8,9
Male Lhb and Lhr knockout mice are azoosper-
mic,10-12 indicating that LH stimulated T production 
is indispensable for spermatogenesis. However, old 
Lhr knockout (LuRKO) mice do show low levels of 
qualitatively complete spermatogenesis, apparently 
due to the residual LH independent T production of 
the immature Leydig cells present in LuRKO tes-
tes.13 This steroidogenesis is either constitutive or 
stimulated by paracrine Sertoli cell factors. Because 
treatment with the antiandrogen flutamide blocks the 
progression from round to elongating spermatids in 
old LuRKO mice, the process is clearly shown to be 
dependent on T stimulation. Although LuRKO mice 
have elevated FSH levels, due to reduced feedback 
inhibition of testicular inhibin, the flutamide effect 
demonstrates that FSH is not able to compensate for 
the lack of T action in this model.
Numerous studies have demonstrated that FSH 
alone is not able to rescue full spermatogenesis in 
gonadotrophin-deficient animals, except for a small 
increase in the number of spermatogonia and pre-
meiotic spermatocytes;7 however, androgen action is 
absolutely necessary for the completion of meiosis, 
progression from round to elongating spermatids and 
spermiogenesis.14-16 
Although Leydig cells produce numerous nonsteroi-
dal paracrine factors, most of the evidence indicates 
that T is the important mediator of LH effects on 
spermatogenesis, occurring through paracrine effects 
of Sertoli cell derived factors. The best evidence for the 
role of Leydig cell factors other than T in spermato-
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testis size in the face of otherwise roughly normal 
spermatogenesis and fertility.28-30 Hence, FSH action 
per se is not necessary for the initiation of spermato-
genesis and maintenance of fertility in mice. The main 
role of FSH is, in synergy with T, to maximize the 
quantity of sperm production.
In adult rat testis, FSH impacts on gonocyte matu-
ration, acts as an antiapoptotic survival factor for 
spermatogonia, spermatocytes and spermatids and 
supports meiosis and spermiogenesis by regulating 
the adhesion complexes between germ and Sertoli 
cells (reviewed by Ruwanpura et al7). The findings 
that FSH treatment increases the numbers of all cell 
types up to round spermatids may be explained by 
increased supply of spermatogonia and ‘passive’ in-
crease in subsequent downstream maturational steps, 
including the meiotic reduction of late pachytene 
spermatocytes to round spermatids. However, sper-
matid elongation was not restored by FSH, indicating 
the need for additional factor(s), most critically T, as 
described above.31
There is also some evidence of FSH support of 
spermatocyte survival and of meiosis, but as the sperm 
mature the role of T becomes more prominent. Ser-
toli cell-specific AR knockout mice have shown that 
FSH alone can support mitosis and meiosis during 
the first spermatogenic wave, but androgen action is 
absolutely necessary for the completion of meiosis, 
spermiogenesis and fertility in adult life.8,9
Humans and other primates
The individual role of FSH in human spermato-
genesis is still largely unexplored, although many 
similarities exist between rodents and man. One 
example comes from men with inactivating FSHR 
mutation who are subfertile with reduced testis size, 
but not azoospermic.32 Likewise, male Fshr and Fshb 
knockout mice are fertile with somewhat suppressed, 
though qualitatively normal, spermatogenesis (see 
above). This indicates that, as in rats and mice, hu-
man spermatogenesis is mainly LH/T-dependent and 
FSH is able to synergize with T to assure qualitatively 
and quantitatively normal spermatogenesis, which 
however is not an absolute prerequisite for fertility. 
Another example of the less crucial role on FSH 
in human spermatogenesis comes from the classical 
genesis comes from comparison of T and LH [using 
the LH agonist human choronic gonadotrophin (hCG)] 
treatments in gonadotrophin-deficient hpg mice.17 
Whereas no difference was found in the production 
of mature sperm, the number of spermatogonia was 
larger after hCG treatment. Hence, some Leydig cell 
factor(s) other than T can promote the proliferation 
and/or survival of spermatogonia. However, high-dose 
T supplementation seems to fully restore the number 
of mature spermatids in LuRKO18,19 and hpg16 mice. 
Furthermore, transcriptome analysis of testes of wild-
type LuRKO and T-treated LuRKO mice showed that 
most of the defects in gene expression in the absence 
of LH action were corrected by T treatment.20
Another potential Leydig cell factor stimulat-
ing spermatogenesis could be insulin-like factor 3 
(INSL3), though it has been shown to be dispensable 
for mouse spermatogenesis.21 However, recent studies 
have shown that INSL3 can promote spermatogonial 
differentiation in zebrafish testis,22,23 providing another 
example of evolutionary divergence in the hormonal 
regulation of gametogenesis. The spermatogenic effect 
of INSL3 thus seems to have been lost in mammals 
during evolution.
Humans and other primates
The overall LH/T effects on spermatogenesis appear 
to be rather similar in most mammalian species, thus no 
major differences exist between rodents and primates 
in this respect. In humans and monkeys, as in rodents, 
T is important for the distal part of spermatogenesis, 
i.e. the conversion of round to elongating spermatids 
and spermiation.15,24 As in rodents, T also acts as an 
antiapoptotic survival factor for spermatocytes and 
spermatids.25
rOLe OF FSH
Rodents
The first actions of FSH on testicular function start 
in rodents postnatally when Sertoli cells acquire Fshr 
expression.26 FSH stimulates Sertoli cell proliferation 
prepubertally and determines their finite number, 
which then determines the size of the testes and the 
quantity of spermatogenesis.27 Further evidence for 
this role of FSH has been obtained from Fshr and 
Fshb knockout mice, which have somewhat reduced 
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study where gonadotrophin-suppressed men were 
treated with hCG, i.e. LH-stimulated T production 
was achieved in the absence of FSH.33 Near-complete 
restoration of spermatogenesis was observed, again 
indicating that the absence of FSH action had only 
limited suppressive effect on spermatogenesis. 
Studies in men with inactivating FSHB or FSHR 
mutations have yielded controversial results. While 
the five men described with an inactivating FSHR 
mutation all have at least some level of spermatogen-
esis, two of them having sired two children each,32 
the three men with inactivating FSHB mutation34-36 
were all azoospermic. Of these men two were found 
in cohorts of azoospermic men, so it is not proven that 
the FSHB mutation detected was the cause of their 
phenotype. Only one of the men was detected as a 
brother of a woman homozygous for the same muta-
tion and with no other abnormality. It is clear that the 
mutation data for or against the compulsory role of 
FSH in the onset and maintenance of spermatogenesis 
in humans are insufficient to allow final conclusions. 
In monkeys, the role of FSH in spermatogenesis 
has long been under debate.37 While there are stud-
ies showing that immunization of monkeys for FSH 
or FSHR brings about azoospermia,38,39 the bulk of 
evidence shows that the FSH dependence of monkey 
spermatogenesis is very similar to that of other mam-
malian species, i.e. FSH is not essential, although it 
synergizes with T to maximize sperm output. 
The overall impression from the existing litera-
ture, albeit all findings do not agree, is that the two 
important roles of FSH in spermatogenesis in rodents 
and man are to regulate the finite number of Sertoli 
cells before puberty and to act as a survival factor of 
premeiotic germ cells. Rather than being a mitogen, 
FSH is a survival factor constraining apoptosis.
Combined action of FSH and T
Besides its support of proliferation and develop-
ment of spermatogonia, FSH synergizes with T to 
support spermiation, i.e. the release of spermatids 
from Sertoli cells.15 In general terms, although there 
is plenty of synergy between FSH and T in the regu-
lation of spermatogenesis, the proximal pre-meiotic 
stages of this process are more FSH-responsive and 
the post-meiotic maturation is critically T-dependent. 
Much of this regulation entails the maintenance of 
balance between cell division and death (apoptosis) 
where FSH and T act as survival factors.7 The FSH 
and T effects in the spermatogenic process converge in 
complementary, synergistic and permissive modes at 
specific phases of the process to maximize its efficacy 
(reviewed by7,40,41). One such effect is the regulation 
of the intrinsic and extrinsic apoptotic pathways of 
spermatogenic cells.7 Synergism is also observed in 
spermatocyte development and spermiation.41
FSH and T cooperation is also indicated by find-
ings that lower doses of either hormone is effective 
when the other one is present.42-44 This view has led 
to the speculation that T and FSH may have com-
mon postreceptor pathways of action,45 evidence 
for which is still lacking, especially since the main 
signaling pathway evoked by FSHR activation, i.e. 
protein kinase A-cyclic AMP, is not stimulated by T. 
However, there are additional signaling systems, like 
MAP kinase and CREB, where FSH and T actions 
can converge.46
It seems that the role of FSH in mammalian sper-
matogenesis is less important, since there are many 
models where spermatogenesis and fertility are main-
tained at sufficient levels without FSH action. One 
can therefore question the necessity and meaning of 
such a weak stimulus of spermatogenesis. Current 
knowledge of the evolution of the two-gonadotrophin 
system could offer an explanation, as will be dis-
cussed below.
SpecIeS DIFFerenceS: evOLuTIOnary 
aSpecTS
Concerning the building blocks of gonadotrophin 
function, i.e. the expression of growth factors with 
cysteine knot structural signature, such as TGFb 
and glycoprotein hormones (GPHs), including gon-
adotrophins, their genes are found in the genome 
of almost all metazoan (multicellular animals) with 
the exception of very primitive forms like the sea 
anemone and sponge.47 Likewise, leucin-rich repeat-
containing G protein-coupled receptors (GPCRs), akin 
to gonadotrophin receptors in higher species, have 
been detected in basal metazoans.47,48 It is therefore 
possible that gonadotrophin action-like regulation of 
reproduction is a very archaic early evolutionary event, 
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Teleost fish are the first evolutionary stage that 
clearly has two gonadotrophins and their cognate 
receptors with partially acquired specificity. Although 
there are exceptions, the general pattern in fishes is 
that Fshr is responsive to both Fsh and Lh, whereas 
Lhr only responds to Lh.55 Besides functional prom-
iscuity, in addition the sites of expression of fish 
gonadotrophin receptors are more relaxed than will 
be the case with higher vertebrates. Taking into ac-
count the earlier appearance of Lh (see above), the 
fact that Lh can activate both Lhr and Fshr and that 
the gonadotrophin-responsive gonadal cells initially 
expressed both gonadotrophin receptors, it is enig-
matic why evolution took the path of introducing the 
two-gonadotrophin system for gonadal regulation. 
The Lh/Lhr system might have been sufficient, as is 
implied by the minor role of Fsh in male mammalian 
fertility (see above). The two gonadotrophins were 
mainly created for the needs of ovarian function.
Zebrafish
It appears that teleost fishes, including the model 
species zebrafish, are halfway through in the evolu-
tion of the specific two-gonadotrophin regulatory 
system of gonadal function. As described before, 
lampreys and hagfish have one gonadotrophin and 
two non-specific gonadotrophin receptors. Teleost 
fishes have acquired two specific gonadotrophins, 
but their cognate receptors still possess some degree 
of promiscuity: Fshr responds to both Fsh and Lh, 
whereas only Lhr is specific for the cognate ligand.57 
Another divergence from the mammalian system 
is that Fshr and Lhr are expressed in fishes both in 
Leydig and Sertoli cells.58,59
Recent studies on gonadotrophin and gonadotro-
phin receptor knockouts in zebrafish using the TALE 
technique60-62 have elucidated the marked special 
features of gonadotrophin action that diverge from 
mammals. Neither lhb nor lhr knockouts affected 
testicular histology, fertilization rate or sperm motility 
in male fishes, indicating that Lh signaling, unlike 
in mammals, is not important for the fertility of the 
male zebrafish. This would indicate the importance 
of Fsh action for male zebrafish fertility. Neverthe-
less, fshb- and fshr-deficient male zebrafish were 
fertile, with only some delay in sexual maturation. 
The promiscuity of Fshr to Lh and Fsh stimulation 
present in the most primitive metazoans. Whether 
gonadotrophin regulation of spermatogenesis starts 
with FSH and/or LH action is crucially dependent on 
the divergence of the two gonadotrophins and their 
receptors during evolution. 
Lower animal species
The most ancestral form of GPHs is thyrostimulin 
whose homologues can be detected both in vertebrates 
and invertebrates, including the fly, nematode and 
sea urchin,49,50 but not in basal animals such as the 
sea anemone.47 It has α and β subunits like all GPHs, 
which have arisen through gene duplication of a 
single ancestral gene.51 These subunits have given 
rise, through another whole-genome duplication, to 
another GPH, which is first detected as the single 
gonadotrophin in the most primitive ancestral agnathan 
(jawless) vertebrates.52-54 Hagfish (or the slime eel) 
and lampreys are the two remaining members of this 
group and considered the most primitive vertebrates 
known, living or extinct. Their single pituitary GPH 
has no specific LH- or FSH-like function. The next 
evolutionary step includes retention of thyrostimulin 
in vertebrates and the divergence of hagfish GTHb to 
Lhb, Fshb and Tshb during additional whole-genome 
duplications. The first duplication product was akin 
to Lhb, after which the common ancestor of Fshb 
and Tshb formed during the next duplication.51 As 
a result of this, most jawed teleost fishes have two 
gonadotrophins, Lh and Fsh, akin to those in mam-
mals.55 However, the biological actions of the two 
primitive fish gonadotrophins are not as well-defined 
as in mammals.
Two glycoprotein hormone receptors, again results 
of gene duplication and functional diversification, 
are first encountered in the lamprey, but it has not 
been possible to classify them unequivocally as being 
specific for Lh, Fsh or Tsh.56 Their overall structure is 
surprisingly close to their mammalian counterparts. 
Interestingly, despite the two gonadotrophin receptors, 
the lamprey has only one gonadotrophin. It is therefore 
understandable that the two lamprey gonadotrophin 
receptors cannot have Lhr- or Fshr-like specificity 
because these two ligands only evolve later. It therefore 
seems that the coevolution of the two-gonadotrophin 
system is driven by the evolution of receptors, which 
is followed by that of the cognate ligands.
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and the coexpression of both gonadotrophin receptors 
in Leydig and Sertoli cells provide an explanation for 
these apparently surprising findings. Double lhb/fshb 
knockout males showed delayed sexual maturation 
but were finally fertile. Infertility with azoospermia 
was only found in lhr/fshr double knockout males. 
The studies show that unlike in mammals, Lh 
action is not needed for zebrafish spermatogenesis 
and is more dependent on Fshr activation. However, 
in the absence of Fsh, Lh can activate Fshr, and in 
the absence of Fshr its effect is compensated for by 
Lh action because both gonadotrophin receptors are 
expressed in Leydig and Sertoli cells. Finally, the 
mild phenotype of combined lhb/fshb deletion can be 
explained by the fact that non-liganded gonadotrophin 
receptors may have a low level of constitutive activ-
ity which is able to maintain a low level of Lhr/Fshr 
activity sufficient to maintain partial spermatogenesis. 
A similar difference is observed in male mice where 
the testicular phenotype is more severe in Fshr than 
Fshb knockout63 apparently for the same reason.
When we now consider the evolution of gonado-
trophin maintenance of spermatogenesis, it seems that 
the specialization of LH and FSH action has occurred 
gradually and taken a different course in various spe-
cies. First, jawless fishes have one gonadotrophin and 
two non-specific gonadotrophin receptors. Thereafter, 
the two gonadotrophins appear in bony fishes, which 
show a relaxed specificity in ligand-receptor interac-
tion. Usually only LHR is specific for the cognate 
hormone and FSH is the dominant gonadotrophin in 
spermatogenesis. The situation will be the opposite 
in mammals, but with some remarkable exceptions. 
The Djungarian hamster
The Djungarian hamster (Phodopus sungorus), a 
seasonally breeding rodent, forms a peculiar exception 
in the mode of hormonal control of spermatogenesis 
amongst mammalian species. Hypophysectomized 
males or those gonadotrophin-suppressed during short 
days (photoinhibited) respond to FSH treatment with 
full recovery of spermatogenesis without simultane-
ous stimulation of Leydig cell steroidogenesis.64-66 In 
contrast, LH alone has a marginal effect on spermato-
genesis even though it restores testicular T production 
to control level. It seems therefore that FSH alone, 
and without additive or synergistic action of T, is 
able to drive the whole spermatogenic process in this 
species. Remarkably, no effect of FSH on Leydig 
cell function, including stimulation of T production, 
could be detected. Furthermore, T synergized with 
FSH in the maintenance of spermatogenesis in the 
Djungarian hamster because sperm production, and 
in particular the number of elongating spermatids, 
was higher in the combined treatment than with FSH 
alone.64 This finding emphasizes the role of T in the 
maturation step from round to elongating spermatids, 
also considered crucial in rodents. 
Further studies in photoinhibited and antiandrogen 
(flutamide) treated animals demonstrated that FSH 
treatment in these conditions was able to increase 
Sertoli cell and spermatogonial numbers and to ad-
vance the premeiotic phases of spermatogenesis.67 
The conditions used were not appropriate to study 
whether FSH would have increased the numbers of 
postmeoiotic germ cells, which leaves the question 
open whether FSH in the absence of T is able to ad-
vance later stages of spermatogenesis. Because a low 
level of T production is possible in the photoinhib-
ited hamster testis in the absence of LH stimulation, 
the current evidence is not sufficient to conclude 
whether postmeiotic maturation of hamster sperm is 
possible with FSH stimulation alone. The least we 
can conclude about the Djungarian hamster is that 
its spermatogenesis is predominantly dependent on 
FSH with a possible supporting role of T, which is 
the opposite to other mammalian species.
pHarmacOLOgIcaL anD geneTIc 
ampLIFIcaTIOn OF FSH acTIOn:  
eFFecTS On SpermaTOgeneSIS
The efficacy of FSH therapy in the treatment of 
oligozoospermia remains a contentious issue.68-70 
The results are variable, although there are some 
promising new leads indicating that specific genetic 
polymorphisms in FSHb and FSHR may cause func-
tional FSH deficiency, in which case FSH therapy 
may improve spermatogenesis.71-73 To be effective, 
FSH therapy will therefore require stratification of 
men according to genotype into FSH-responsive and 
non-responsive individuals. 
Another explanation for the poor outcome of the 
FSH treatments is that the doses used have been 
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too small, and to be effective they have to be phar-
macological. Paradisi et al74,75 and Ding et al76 have 
observed in placebo-controlled studies that a high 
dose of recombinant FSH (300 IU every other day 
for ≥4-5 months), instead of the standard dose of 75 
IU/every other day, significantly increased sperm 
counts and pregnancy rates. 
The success of treatment with higher FSH doses 
may have relevance to some additional findings in 
the involvement of FSH in spermatogenesis. Gromoll 
et al reported in 199677 a hypophysectomized male 
who had normal spermatogenesis despite unmeasur-
able gonadotrophin levels. He was found to carry a 
D567G mutation in exon 10 of FSHR, which evoked 
marginal constitutive activity of FSHR. Replica-
tion of the same mutation in transgenic mice in the 
gonadotrophin-deficient hpg background increased 
the number of FSH-responsive Sertoli cells, spermato-
gonia and postmeiotic germ cells, but did not lead to 
full spermatic maturation. Hence, although the mouse 
model confirmed the constitutive biological activ-
ity of the human D567G FSHR mutation, it did not 
confirm the human finding of full spermatogenesis. 
Furthermore, these models were confounded by the 
paracrine stimulation of Leydig cell T production by 
the FSH-stimulated Sertoli cells, which made it dif-
ficult to decipher whether the spermatogenic effect 
was due to this effect or direct Sertoli cell stimula-
tion by the mutant FSHR. Our very recent findings 
(Oduwole et al, manuscript in preparation) of fully 
compensated spermatogenesis in another genetically 
modified mouse model of a strongly activating Fshr 
mutation expressed in the Lhr-/- background suggests 
that the spermatogenesis in the male patient may re-
ally be due to the FSHR mutation and that the lack 
of a full phenocopy in the mouse may be due to too 
weak activity of the human gain-of-function FSHR 
mutation in the mouse. 
Taken together, these findings suggest that very 
strong FSHR stimulation can compensate for the lack 
of androgen stimulation in spermatogenesis and that 
T and FSH can totally compensate for each other, 
provided that the level of stimulation of the remain-
ing hormone is strong enough. Hence, there seem 
to be no specific stages of spermatogenesis that are 
exclusively T- or FSH-dependent. The dose may be 
critical when treating oligozoospermia with FSH and 
the typically used doses may have been insufficient. 
Finally, the currently accepted assumption that T is 
a ‘sine qua non’ in spermatogenesis may not be true. 
Almost the same can be achieved with FSH, but it 
requires pharmacological doses.
cOncLuDIng remarKS
In this review we have made an evolutionay jour-
ney from lamprey to humans in the gonadotrophin 
regulation of spermatogenesis (Figure 1). The regula-
Figure 1. The gonadotrophins, their receptors, specificity of the interaction and dominant gonadotrophin in the regulation of spermato-
genesis in the species discussed in the text. The abbreviations of the molecules are according to the Committee on Genetic Symbols 
and Nomenclature (1957). Union of International Sci Biol Ser B, Colloquia No. 30.
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tion starts from the action of a single gonadotrophin 
on two non-specific receptors in the slime eel and 
lamprey, and moves to jawed fishes in which FSH 
is the dominant gonadotrophin in a situation where 
FSHR has relaxed ligand specificity to FSH and LH 
and where both gonadotrophin receptors are expressed 
in Sertoli and Leydig cells. When evolution reaches 
mammals, LHR and FSHR have become specific 
for their cognate ligands and are expressed only in 
Leydig or Sertoli cells, respectively. FSH can still in 
a paracrine fashion, through Sertoli cells, stimulate 
some T production, but in mammals in general LH is 
the driving force of spermatogenesis. The Djungarian 
hamster forms a remarkable exception that proves the 
rule, maintaining the fish-like FSH-dependent pattern 
of spermatogenic regulation. The real importance of 
FSH in the regulation of mammalian spermatogenesis 
still remains an enigma, since many mammalian models 
seem to maintain sufficient spermatogenesis in the 
absence of FSH. The effect of strong FSH stimula-
tion on mammalian spermatogenesis appears to hark 
back to the evolutionarily earlier fish and suggests 
that higher than previously presumed doses of FSH 
may be effective in the treatment of male infertility. 
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